Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Traditional tumor-targeted drug delivery faces challenges due to tumor biological complexity and nano-system design limitations.
• The enhanced permeability and retention (EPR) effect and receptor-mediated endocytosis have limitations in achieving effective tumor targeting.
• Multistage drug delivery systems (Ms-DDS) offer a promising alternative by adapting to diverse biological environments.

Purpose of the Study:

• To review the mechanisms and recent advances in multistage drug delivery systems (Ms-DDS) for tumor therapy and imaging.
• To highlight the advantages of Ms-DDS in overcoming the limitations of traditional drug delivery systems.
• To discuss the potential and future prospects of multi-stimuli responsive Ms-DDS.

Main Methods:

• Review of literature on multistage nanoparticle systems and their response to tumor microenvironment stimuli.
• Analysis of how Ms-DDS modify physicochemical properties (size, hydrophobicity, zeta potential) in response to physiological differences.
• Discussion of mechanisms including deeper tumor penetration, enhanced cellular uptake, controlled drug release, and endosomal escape.

Main Results:

• Ms-DDS demonstrate adaptability to tumor microenvironment and intracellular conditions, leading to improved drug delivery.
• Multi-stimuli responsive Ms-DDS show enhanced therapeutic efficacy by delivering drugs to specific tumor sites, cells, and organelles.
• These systems offer potential for maximizing drug quantity at therapeutic targets.

Conclusions:

• Ms-DDS represent a significant advancement in tumor-targeted drug delivery, offering superior control and efficacy.
• The multi-stimuli responsive nature of these systems is key to their enhanced performance in complex tumor environments.
• Ms-DDS hold considerable promise for future cancer therapy and diagnostic applications.